Mirae Asset Global Investments’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $50.8K | Buy |
3,431
+462
| +16% | +$6.84K | ﹤0.01% | 1252 |
|
2025
Q1 | $58.4K | Buy |
2,969
+108
| +4% | +$2.13K | ﹤0.01% | 1211 |
|
2024
Q4 | $49.4K | Buy |
2,861
+94
| +3% | +$1.62K | ﹤0.01% | 1267 |
|
2024
Q3 | $38.8K | Buy |
2,767
+494
| +22% | +$6.92K | ﹤0.01% | 1345 |
|
2024
Q2 | $18.8K | Sell |
2,273
-47,905
| -95% | -$397K | ﹤0.01% | 1386 |
|
2024
Q1 | $804K | Buy |
50,178
+3,754
| +8% | +$60.2K | ﹤0.01% | 1651 |
|
2023
Q4 | $417K | Buy |
46,424
+3,083
| +7% | +$27.7K | ﹤0.01% | 2054 |
|
2023
Q3 | $387K | Sell |
43,341
-5,326
| -11% | -$47.6K | ﹤0.01% | 2011 |
|
2023
Q2 | $747K | Buy |
48,667
+4,767
| +11% | +$73.1K | ﹤0.01% | 1748 |
|
2023
Q1 | $987K | Buy |
43,900
+12,340
| +39% | +$278K | ﹤0.01% | 1556 |
|
2022
Q4 | $664K | Buy |
31,560
+28
| +0.1% | +$589 | ﹤0.01% | 1726 |
|
2022
Q3 | $777K | Buy |
31,532
+12,290
| +64% | +$303K | ﹤0.01% | 1623 |
|
2022
Q2 | $466K | Buy |
+19,242
| New | +$466K | ﹤0.01% | 1784 |
|